At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
XPH Spdr S&P Pharmaceuticals Etf
Trading 08-19 13:06:56 EDT
73.73
+1.28
+1.77%
High74.35Low73.44Vol64.15K
Open73.50D1 Closing72.45Amplitude1.25%
Mkt Cap556.68MTradable Cap556.68MTotal Shares7.55M
T/O4.73MT/O Rate0.85%Tradable Shares7.55M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BMO starts Exelixis at Market Perform into patent cliff
TIPRANKS  ·  08-19 04:30
BMO starts Exelixis at Market Perform into patent cliff
AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape
Stock News  ·  08-03
AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape
HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer
Stock News  ·  07-08
HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer

Introduction

Company Name.
Spdr S&P Pharmaceuticals Etf
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Issue price:
--